Trial Profile
Endocrine and metabolic effects of valproate in premenopausal women with affective psychosis
Status:
Active, no longer recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 25 Sep 2006
Price :
$35
*
At a glance
- Drugs Valproate semisodium (Primary) ; Neuropsychotherapeutics
- Indications Bipolar disorders; Schizoaffective disorder
- Focus Adverse reactions
- 25 Sep 2006 New trial record.